Alternative Metalloporphyrins for the Treatment of Neonatal Jaundice

[1]  Vinod K. Bhutani,et al.  Noninvasive Measurement of Total Serum Bilirubin in a Multiracial Predischarge Newborn Population to Assess the Risk of Severe Hyperbilirubinemia , 2000, Pediatrics.

[2]  D. Stevenson,et al.  Carbon Monoxide in Breath, Blood, and Other Tissues , 2000 .

[3]  D K Stevenson,et al.  Zinc protoporphyrin: A metabolite with a mission. , 1999, Clinical chemistry.

[4]  D. Stevenson,et al.  Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[5]  D. Stevenson,et al.  Carbon Monoxide Production and Upregulation of Heme Oxygenase Activity in Mice after Heme Administration , 1999 .

[6]  D. Stevenson,et al.  Concentration of Carbon Monoxide (CO) in Tissue , 1999 .

[7]  A. Kappas,et al.  Control of Severe Hyperbilirubinemia in Full-term Newborns With the Inhibitor of Bilirubin Production Sn-Mesoporphyrin , 1999, Pediatrics.

[8]  D. Stevenson,et al.  In Vitro Heme Oxygenase Isozyme Activity Inhibition by Metalloporphyrins • 1176 , 1998, Pediatric Research.

[9]  D. Stevenson,et al.  Duration of Action and Tissue Distribution of Zinc Protoporphyrin in Neonatal Rats , 1996, Pediatric Research.

[10]  J. Tyson,et al.  Interlaboratory variability of bilirubin measurements. , 1996, Clinical chemistry.

[11]  D. Stevenson,et al.  Characterization of porphyrin heme oxygenase inhibitors. , 1996, Canadian journal of physiology and pharmacology.

[12]  D. Stevenson,et al.  Advances in the diagnosis and treatment of neonatal hyperbilirubinemia. , 1995, Clinics in perinatology.

[13]  C. Henschke,et al.  Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. , 1994, Pediatrics.

[14]  D. Stevenson,et al.  Selection of Metalloporphyrin Heme Oxygenase Inhibitors Based on Potency and Photoreactivity , 1993, Pediatric Research.

[15]  M. Maines.  Heme Oxygenase: Clinical Applications and Functions , 1992 .

[16]  D. Stevenson,et al.  In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG. , 1991, The American journal of the medical sciences.

[17]  D. Stevenson,et al.  In Vitro Inhibition of Adult Rat Intestinal Heme Oxygenase by Metalloporphyrins , 1989, Pediatric Research.

[18]  N. Abraham,et al.  Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin , 1989, Hepatology.

[19]  D. Stevenson,et al.  The use of metalloporphyrins for the chemoprevention of neonatal jaundice. , 1989, American journal of diseases of children.

[20]  M. Maines.  Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Kappas,et al.  Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. , 1988, Pediatrics.

[22]  A. Kappas,et al.  Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism. , 1987, Archives of biochemistry and biophysics.

[23]  G. Drummond,et al.  Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal. , 1986, The Journal of clinical investigation.

[24]  M. Maines,et al.  Prevention of neonatal hyperbilirubinaemia in non-human primates by Zn-protoporphyrin. , 1985, The Biochemical journal.

[25]  H. Marver,et al.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D K Stevenson,et al.  Carbon monoxide and carboxyhemoglobin. , 1995, Advances in pediatrics.

[27]  H. Vallier,et al.  Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins. , 1993, Life sciences.

[28]  D. Rosenberg,et al.  Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins. , 1992, Gastroenterology.

[29]  H. Vallier,et al.  Oral administration of zinc deuteroporphyrin IX 2,4 bis glycol inhibits heme oxygenase in neonatal rats. , 1991, Developmental pharmacology and therapeutics.

[30]  K Nakatsu,et al.  Does carbon monoxide have a physiological function? , 1991, Trends in pharmacological sciences.

[31]  M. Maines.  Zinc . protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. , 1981, Biochimica et biophysica acta.